Fidelity & Guaranty Life Insurance Company Sells Shares Under Rule 10b5-1
Crescent Capital BDC, Inc. recently announced that Fidelity & Guaranty Life Insurance Company, which owns a ten percent stake in the company, has sold 56,285 shares of Common Stock over two days in early September 2026.
These transactions, executed under a Rule 10b5-1 trading plan, saw 11,285 shares sold at $10.50 per share on September 1. The following day, an additional 45,000 shares were sold at a volume-weighted average price of approximately $10.44 per share, with the prices ranging from $10.38 to $10.59. Notably, some of these shares are held by Fidelity & Guaranty Life Insurance Company of New York, a wholly-owned subsidiary of the primary stakeholder.
Implications for Insurance Industry Stakeholders
The sale of shares by Fidelity & Guaranty Life Insurance underlines strategic portfolio management tendencies common within the insurance sector. Such transactions can offer insight into the company’s strategic financial planning and liquidity management. Insurance professionals should consider these activities when analyzing market moves, particularly under 10b5-1 plans, which provide a mechanism for corporate insiders to trade stock in ways that are compliant with insider trading regulations.
Transaction Breakdown
| Date | Shares Sold | Price Range |
|---|---|---|
| September 1, 2026 | 11,285 | $10.50 |
| September 2, 2026 | 45,000 | $10.38 - $10.59 |
For professionals in the insurance sector, understanding the movement and motivations behind such significant stock sales is essential. It reflects broader trends in investment strategies and the importance of managing regulatory compliance, especially under Rule 10b5-1, which allows predetermined stock sales to occur without conflict with insider trading laws. This strategic divestment may indicate organizational adjustments that could impact future business decisions and market strategies.